慢性胺使用患者的"K",反复出现的腹痛:一个病例报告
Tucker Avra1, Jesus Torres2, Kumar Felipe Vasudevan3
1UCLA David Geffen School of Medicine, Los Angeles, California.
紧急服务部门应考虑在患有不明原因疼痛的患者中使用慢性胺胺. 停止服用胺可以快速改善症状,突出了需要药物使用障碍治疗的需要.
科学领域:
- 毒理学 毒理学 毒理学
- 紧急医疗 紧急医疗
- 成 药物 药物 药物 药物
背景情况:
- 非医疗胺使用量正在增加,导致因相关副作用而增加急诊室 (ED) 访问.
- 医生需要有效的策略来识别和管理胺相关的并发症.
研究的目的:
- 突出考虑慢性胺使用在出现不明原因胃肠道和泌尿症状的患者中的重要性.
- 强调需要及时诊断和管理胺诱导的后果.
主要方法:
- 一份病例报告显示,一名31岁的男性慢性非医疗胺使用,出现严重的非创伤性背部和腹部疼痛.
- 对临床表现,诊断工作和患者对切断胺药物的反应的审查.
主要成果:
- 一个长期使用胺的患者经历了严重的腹部和背部疼痛,对传统的治疗没有反应.
- 停止服用胺导致症状在24小时内迅速改善.
- 患者通过在线资源自认胺为原因,并寻求成治疗.
结论:
- 紧急医生应该考虑胺使用障碍作为无法解释的胃肠道和泌尿症状的差异诊断.
- 管理应包括患者教育,症状治疗以及与减少危害和物质使用障碍服务的联系.
更多相关视频
02:41Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
Published on: May 3, 2024
05:42Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
Published on: January 7, 2019
相关概念视频
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
